Pharma Division of Deep Knowledge Analytics has recently launched a new series of proprietary analytics, integrated summaries of which can be reviewed here.

This series currently includes the following 7 reports, which will be updated quarterly and systematically extended by the addition of new special case studies:

Comparative Industry Analysis and Classification Framework (updated monthly);
Declining Efficiency of R&D in Pharma Corporations;
Pharma AI Stock Index;
- Analysis of Leading Investors in the AI for Drug Discovery Sector;
- Top-30 AI-Pharma Analysts;
- Defining Hype vs Reality in AI for Drug Discovery Sector;
- Enhanced Comparative Analysis of Leading AI-startups.

You can read about our analytics methodology here.

We look forward to your feedback, and in case of interest please contact us at [email protected].

Deep Knowledge Analytics proudly supports the AI Applications in Biopharma Summit.

Confirmed Sponsors


Never miss an announcement

/* */